All In Biotech

Free tool

FAERS Monitor: Gralise

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022544 or its brand name (Gralise, Gabapentin). Reports on generic versions are filed under their own applications.

Reports

300,733

Serious

189,916

63% of reports

Hospitalization

87,410

Death reported

29,651

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective23,993
  • fatigue21,544
  • nausea18,926
  • off label use17,906
  • pain17,036
  • diarrhoea15,598
  • headache14,835
  • dizziness13,449
  • fall12,687
  • dyspnoea11,776
  • vomiting10,041
  • death9,961
  • arthralgia9,707
  • asthenia9,637
  • pain in extremity9,381

Reports by year received

View as table
YearReports
2004874
20051,392
20061,193
20071,391
20081,882
20092,372
20103,430
20113,989
20126,183
20137,179
20149,856
201516,498
201621,037
201722,746
201827,102
201929,628
202025,935
202122,045
202220,707
202320,248
202419,735
202520,633
202614,677

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,753,426 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
fallSignal12,6872.72.713,614
pain in extremitySignal9,3812.32.26,522
pain17,0362.01.98,103
fatigue21,5442.01.910,259
dizziness13,4491.91.95,814
asthenia9,6371.81.83,487
diarrhoea15,5981.71.74,598
nausea18,9261.71.75,393
headache14,8351.71.64,019
arthralgia9,7071.61.62,463
vomiting10,0411.51.51,699
dyspnoea11,7761.51.41,746
off label use17,9061.41.42,452
drug ineffective23,9931.31.31,523
death9,9610.80.8477

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.